Short Interest in China Pharma Holdings, Inc. (NYSE:CPHI) Decreases By 29.7%

China Pharma Holdings, Inc. (NYSE:CPHI) saw a significant decrease in short interest in the month of May. As of May 31st, there was short interest totalling 44,600 shares, a decrease of 29.7% from the May 15th total of 63,400 shares. Based on an average daily volume of 82,400 shares, the short-interest ratio is presently 0.5 days. Approximately 2.0% of the shares of the company are sold short.

China Pharma Stock Up 13.3%

CPHI stock opened at $1.85 on Tuesday. The company has a debt-to-equity ratio of 0.22, a quick ratio of 0.26 and a current ratio of 0.79. China Pharma has a 1 year low of $1.20 and a 1 year high of $3.35. The stock’s fifty day moving average price is $3.08 and its 200-day moving average price is $15.15.

Analysts Set New Price Targets

Separately, Wall Street Zen upgraded shares of China Pharma from a “sell” rating to a “hold” rating in a report on Wednesday, May 21st.

China Pharma Company Profile

China Pharma Holdings, Inc develops, manufactures, and markets generic and branded pharmaceutical, and biochemical products to hospitals and private retailers in the People’s Republic of China. The company provides products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions.